55PDIdentification of biological axes associated with stage II/III CRC recurrence risk and outcome after adjuvant therapy revealed a T-effector-independent prognostic role for granzyme B.
Saved in:
| Title: | 55PDIdentification of biological axes associated with stage II/III CRC recurrence risk and outcome after adjuvant therapy revealed a T-effector-independent prognostic role for granzyme B. |
|---|---|
| Authors: | Thakur, M Das1 (AUTHOR), Udyavar, A1 (AUTHOR), Sandmann, T2 (AUTHOR), Li, C1 (AUTHOR), Bosch, L J W3 (AUTHOR), O'Gorman, W1 (AUTHOR), Li, Y1 (AUTHOR), Au-Yeung, A1 (AUTHOR), Takahashi, C1 (AUTHOR), Bourgon, R1 (AUTHOR) |
| Source: | Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdy269.053 |
